Jan Skvarka

Insider Reports History

Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
Signature
/s/ Andrea Paul, attorney-in-fact for Jan Skvarka
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jan Skvarka:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Director Common Stock 207K $267K $1.29 Jun 17, 2025 Direct
Monte Rosa Therapeutics, Inc. Director Stock Option (Right to Buy) 30.7K Jun 13, 2025 Direct
Trillium Therapeutics Inc. President and CEO, Director Common Shares 0 May 12, 2021 Direct
Trillium Therapeutics Inc. President and CEO, Director Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Jan Skvarka

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZNTL Zentalis Pharmaceuticals, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 13, 2025 1 $0 4 Jun 16, 2025 Director
ZNTL Zentalis Pharmaceuticals, Inc. Jan 31, 2025 1 $103K 4 Feb 4, 2025 Director
ZNTL Zentalis Pharmaceuticals, Inc. Jun 21, 2024 1 $0 4 Jun 21, 2024 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Director
ZNTL Zentalis Pharmaceuticals, Inc. Sep 11, 2023 1 -$125K 4 Sep 13, 2023 Director
ZNTL Zentalis Pharmaceuticals, Inc. Jun 16, 2023 1 $0 4 Jun 16, 2023 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
GLUE Monte Rosa Therapeutics, Inc. Mar 30, 2023 1 $0 4 Mar 31, 2023 Director
GLUE Monte Rosa Therapeutics, Inc. Mar 23, 2023 0 $0 3 Mar 24, 2023 Director
ZNTL Zentalis Pharmaceuticals, Inc. Sep 9, 2022 1 $0 4 Sep 12, 2022 Director
ZNTL Zentalis Pharmaceuticals, Inc. Sep 9, 2022 0 $0 3 Sep 12, 2022 Director
TRIL Trillium Therapeutics Inc. Nov 17, 2021 3 $0 4 Nov 19, 2021 President and CEO, Director
TRIL Trillium Therapeutics Inc. May 11, 2021 8 -$1.15M 4 May 13, 2021 President and CEO, Director